title: In Reply to "The effect of tolvaptan on kidney function in patients with autosomal dominant polycystic kidney disease".
authors.affiliation: Department of Urology, Juntendo University Graduate School of Medicine, Hongo 3-1-3, Bunkyo-ku, Tokyo, 113-8431, Japan. shorie@juntendo.ac.jp.
authors.forename: Shigeo
authors.initials: S
authors.lastname: Horie
authors.affiliation: Department of Urology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-Ku, Tokyo, 173-8605, Japan. muto@med.teikyo-u.ac.jp.
authors.forename: Satoru
authors.initials: S
authors.lastname: Muto
mesh_terms: D065092:Antidiuretic Hormone Receptor Antagonists / Q000627:therapeutic use*; D001552:Benzazepines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D016891:Polycystic Kidney, Autosomal Dominant / Q000188:drug therapy*
chemical_list: D065092:Antidiuretic Hormone Receptor Antagonists; D001552:Benzazepines